Omnimmune Holdings, Inc.

OTC: OMMH · Healthcare · Biotechnology

PublicHQ Houston, TXReports USD

#1 of 1,402 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 27

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ workforce scale, market scale

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

Market cap

$981

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Omnimmune Holdings, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

TetraLogic Pharmaceuticals Corporation——Micron Solutions, Inc.——BioELife Corp.——American Medical Technologies Inc.——

Key facts

CEOSaul Leal

SectorHealthcare

IndustryBiotechnology

HeadquartersHouston, TX

ExchangeOTC: OMMH

Employees2

IPO date2007-12-19

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.